C0373483||screening
C1510438||assay
C1819995||host cell
C0003451||antiviral targets
C0011226||hepatitis D virus infection
C0011220||Hepatitis delta virus
C0011220||Hepatitis delta virus
C0036238||minimalistic satellite virus
C0019169||hepatitis B virus
C0019169||hepatitis B virus
C0011220||Hepatitis delta virus
C0275524||co-infection
C0011226||hepatitis D
C0042721||viral hepatitis
C0087111||therapy
C0011226||HDV infection
C0011220||Hepatitis delta virus
C0042776||virus
C0014442||drugable enzyme
C0017428||genome
C2603343||study
C0025663||semi-automated method
C0220825||evaluate
C0011226||HDV infection
C0042774||replication
C1254351||drugs
C0007600||Huh-7/hNTCP cell culture
C4283957||well plate format
C0181839||microscope
C0936012||analysis
C0037589||CellProfiler software
C1254351||drugs
C0011226||HDV infection
C1519941||validation
C0003451||anti-HDV agents
C0220825||evaluated
C0080125||ribozyme
C0243102||activity
C0486926||HDV RNA
C0373483||screened
C0080125||ribozyme
C0014432||inhibitors
C1155328||antiviral
C0301974||mediators
C0021734||interferons alpha-2a
C0254119||beta-1a
C0011226||HDV infection
C0373483||screened
C0023621||library
C0086418||human
C3537035||kinase inhibitors
C0086418||human
C3829378||kinome
C0014432||inhibitors
C0033640||tyrosine kinase-like group
C1155328||anti-HDV activity
C1254351||substances
C0768461||kenpaullone
C0244988||GSK-3Î²
C1511576||Cdk inhibitor
C0918012||selective index
C0025663||tool
C0220908||screen
C1254351||substances
C1155328||anti-HDV activity
C0233820||insights
C0011220||Hepatitis delta virus
C0042774||replication
C0086418||human
C3829378||kinome